0 items USD 0.00Search
Your search for "delveinsight chronic lymphocytic leukemia cll api insights 2017" gave back 17643 results.
The global Bruton Tyrosine Kinase (BTK) Inhibitor market size is projected to grow from US$ 866.7 million in 2022 to US$ 1834.6 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Bruton Tyrosine Kinase (BTK) Inhibitor market size was valued at USD 911.6 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Bendamustine market size was valued at US$ 775.1 million in 2023. With growing demand in downstream market, the Bendamustine is forecast...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Bruton Tyrosine Kinase (BTK) Inhibitor market size is expected to reach $ 1825.9 million by 2029, rising at a market growth of 10.4% CAGR...
Catalog:
GIR
July 2023
Price: USD 4,480.00
Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market The global B-Cell Chronic Lymphocytic Leukemia Treatment...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Imbruvica market size was valued at US$ million in 2023. With growing demand in downstream market, the Imbruvica is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global CD20 Target Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of...
Catalog:
GIR
November 2023
Price: USD 3,480.00
Acalabrutinib (ACP-196) is an orally active, irreversible, and highly selective second-generation BTK inhibitor. Acalabrutinib binds covalently to...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
